KB Financial Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $36K | Hold |
319
| – | – | 0.01% | 293 |
|
|
2023
Q2 | $30K | Hold |
319
| – | – | 0.01% | 325 |
|
|
2023
Q1 | $32K | Sell |
319
-45
| -12% | -$4.51K | 0.01% | 314 |
|
|
2022
Q4 | $43K | Sell |
364
-71
| -16% | -$8.39K | 0.01% | 276 |
|
|
2022
Q3 | $46K | Hold |
435
| – | – | 0.02% | 254 |
|
|
2022
Q2 | $42K | Buy |
435
+43
| +11% | +$4.15K | 0.01% | 265 |
|
|
2022
Q1 | $37K | Hold |
392
| – | – | 0.01% | 301 |
|
|
2021
Q4 | $33K | Buy |
+392
| New | +$33K | 0.01% | 331 |
|
|
2021
Q3 | – | Sell |
-397
| Closed | -$39K | – | 426 |
|
|
2021
Q2 | $39K | Sell |
397
-48
| -11% | -$4.72K | 0.01% | 287 |
|
|
2021
Q1 | $43K | Buy |
+445
| New | +$43K | 0.02% | 280 |
|